Morgan Stanley’s Vigil Neuroscience VIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-13,091
Closed -$104K 8388
2025
Q2
$104K Sell
13,091
-87,074
-87% -$390K ﹤0.01% 6123
2025
Q1
$178K Buy
100,165
+100,154
+910,491% +$225K ﹤0.01% 5775
2024
Q4
$19 Hold
11
﹤0.01% 7877
2024
Q3
$37 Sell
11
-19,830
-100% -$73.5K ﹤0.01% 7673
2024
Q2
$79.4K Sell
19,841
-3,521
-15% -$12.1K ﹤0.01% 6044
2024
Q1
$79.7K Sell
23,362
-86,466
-79% -$270K ﹤0.01% 6076
2023
Q4
$371K Buy
109,828
+97,469
+789% +$501K ﹤0.01% 5731
2023
Q3
$66.6K Sell
12,359
-3,266
-21% -$22.6K ﹤0.01% 6047
2023
Q2
$147K Sell
15,625
-42,719
-73% -$404K ﹤0.01% 5777
2023
Q1
$571K Buy
58,344
+49,252
+542% +$554K ﹤0.01% 5178
2022
Q4
$114K Buy
9,092
+8,962
+6,894% +$110K ﹤0.01% 5926
2022
Q3
$1K Sell
130
-3,208
-96% -$23.5K ﹤0.01% 7613
2022
Q2
$7K Buy
3,338
+2,462
+281% +$9.72K ﹤0.01% 7329
2022
Q1
$7K Buy
+876
New +$11.6K ﹤0.01% 7513

Other funds holding VIGL